Advertisement
Advertisement

ACXP

ACXP logo

Acurx Pharmaceuticals, Inc. Common Stock

0.6822
USD
+0.09
+13.60%
Feb 21, 15:59 UTC -5
Closed
exchange

After-Market

0.776

+0.09
+13.75%

Acurx Pharmaceuticals, Inc. Common Stock Profile

About

Acurx Pharmaceuticals Inc. is a clinical stage biopharmaceutical company. It focused on developing new antibiotics to treat infections. Acurx Pharmaceuticals Inc. is based in STATEN ISLAND, N.Y.

Info & Links

CEO

David P. Luci

Headquarters

259 LIBERTY AVENUE
STATEN ISLAND, NY 10305, UNITED STATES

Sector

Medical

Auditor

CohnReznick LLP

Share holders

--

Employees

4

Acurx Pharmaceuticals, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

13.11M

Enterprise Value

7.35M

Enterprise Value/EBITDA(ttm)

-0.45

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

4.16

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-392.36%

Return on Invested Capital(ttm)

-408.75%

Return on Assets(ttm)

-223.78%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-16.44M

Net Income Available to Common(ttm)

-16.44M

Diluted EPS(ttm)

-1.09

Share Statistics

Beta (5Y Monthly)

-1.72

52-Week Change

-78.20%

S&P 500 52-Week Change

18.16%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

16.89M

Dividend Yield

0.00%

Float4

11.99M

% Held by Insiders

29.60%

% Held by Institutions

11.53%

Balance Sheet

Total Cash(mrq)

5.76M

Total Cash Per Share(mrq)

0.34

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

1.80%

Quick Ratio(mrq)

1.80%

Book Value Per Share(mrq)

0.16

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.50

Free Cash Flow(ytd)

-8.13M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement